We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Once a growth area in both the United States and Europe, the job market for HIV/AIDS is now flattening out. These days, a scientific career in HIV/AIDS research is more likely to involve clinical-research programmes in developing nations than basic research in Western countries.

In this article, Myrna Watanabe reports that this shift has been driven by funding. The amount of money earmarked for HIV/AIDS is massive, and the focus is now being put on developing countries.

For example, as part of the ‘3 by 5’ initiative announced recently by the World Health Organisation, money will be available for Western scientists to train physicians in the developing world (see Anti-AIDS drugs sought for 3 million). And even in industry, job openings are often linked to those regions most affected by the disease.

Link to full article in Nature 

Reference: Nature 426, 737 (2003)

Related topics